| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on July 11, 2003
Accepted on December 8, 2003
1 Department of Research, Saint Francis Hospital and Medical Center, Hartford, CT and The University of Connecticut School of Medicine, Farmington, CT
* To whom correspondence should be addressed. E-mail: ecanalis{at}stfranciscare.org.
CCAAT/enhancer binding protein (C/EBP) homologous protein (CHOP/DDIT3), a member of the C/EBP family of transcription factors, plays a role in cell survival and differentiation. CHOP/DDIT3 binds to C/EBPs to form heterodimers that do not bind to consensus Cebp sequences, acting as a dominant negative inhibitor. CHOP/DDIT3 blocks adipogenesis, and we postulated it could induce osteoblastogenesis. We investigated the effects of constitutive CHOP/DDIT3 overexpression in murine ST-2 stromal cells transduced with retroviral vectors. ST-2 cells differentiated toward osteoblasts, and CHOP/DDIT3 accelerated and enhanced the appearance of mineralized nodules, and the expression of osteocalcin and alkaline phosphatase mRNAs, particularly in the presence of bone morphogenetic protein-2. CHOP/DDIT3 overexpression opposed adipogenesis, and did not cause substantial changes in cell number. CHOP/DDIT3 overexpression did not modify C/EBP
or
mRNA levels, but decreased C/EBP
after 24 days of culture. Electrophoretic mobility shift and supershift assays demonstrated that overexpression of CHOP/DDIT3 decreased the binding of C/EBPs to their consensus sequence by interacting with C/EBP
and
, confirming its dominant negative role. In addition, CHOP/DDIT3 enhanced BMP-2/Smad signaling. In conclusion, CHOP/DDIT3 enhances osteoblastic differentiation of stromal cells, in part by interacting with C/EBP
and
, and also by enhancing Smad signaling.
This article has been cited by other articles:
![]() |
N. Wiper-Bergeron, C. St-Louis, and J. M. Lee CCAAT/Enhancer Binding Protein {beta} Abrogates Retinoic Acid-Induced Osteoblast Differentiation via Repression of Runx2 Transcription Mol. Endocrinol., September 1, 2007; 21(9): 2124 - 2135. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shirakawa, S. Maeda, T. Gotoh, M. Hayashi, K. Shinomiya, S. Ehata, R. Nishimura, M. Mori, K. Onozaki, H. Hayashi, et al. CCAAT/Enhancer-Binding Protein Homologous Protein (CHOP) Regulates Osteoblast Differentiation. Mol. Cell. Biol., August 1, 2006; 26(16): 6105 - 6116. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Bek, M. Bayer, B. Muller, S. Greiber, D. Lang, A. Schwab, C. August, E. Springer, R. Rohrbach, T. B. Huber, et al. Expression and Function of C/EBP Homology Protein (GADD153) in Podocytes Am. J. Pathol., January 1, 2006; 168(1): 20 - 32. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Harrison, Y.-F. Huang, K. A. Wilson, P. L. Kelly, D. J. Adams, G. A. Gronowicz, and S. H. Clark Col1a1 Promoter-targeted Expression of p20 CCAAT Enhancer-binding Protein {beta} (C/EBP{beta}), a Truncated C/EBP{beta} Isoform, Causes Osteopenia in Transgenic Mice J. Biol. Chem., March 4, 2005; 280(9): 8117 - 8124. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gery, D. J. Park, P. T. Vuong, D. Y. Chih, N. Lemp, and H. P. Koeffler Retinoic acid regulates C/EBP homologous protein expression (CHOP), which negatively regulates myeloid target genes Blood, December 15, 2004; 104(13): 3911 - 3917. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |